ClinicalTrialsFinder

Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Clinical Trials in Wuhan, Hubei

1 recruitingWuhan, Hubei, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Systemic Sclerosis Associated Interstitial Lung DiseaseRheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.30 enrolled4 locationsNCT06189495